Disseminated Saksenaea infection in an immunocompromised host associated with a good clinical outcome: a case report and review of the literature

Table 1 Reported cases of disseminated Saksenaea spp. infection

Case	Age	Sex	Country/year	Comorbidities	Mode of Infection	Organism	Method of identification	Organ systems involved	Treatment	Outcome
1 [14]	69	Female	United States of America 1981	Acute myeloid leukaemia	Inhalation	Saksenaea sp.	Phenotypic	Cutaneous, Pulmonary, Renal	Nil	Died
2 [15]	58	Male	Spain 2014	Type 2 Diabetes Mellitus	Trauma	Saksenaea vasiformis complex	Genotypic (ITS sequencing)	Cutaneous, Ocular, Cerebral	Surgical debridement, IV Amphotericin B	Died
3 [16]	59	Male	Australia 2000	Hypertension, Asthma	Inhalation	Saksenaea sp.	Phenotypic	Cutaneous, Cardiac, Pulmonary, Thyroid	Surgical debridement, IV Amphotericin B	Died
4 [17]	11	Male	Australia 2008	Nil	Insect bite	Saksenaea sp.	Phenotypic	Cutaneous, Renal	Surgical debridement, IV Amphotericin B, Posaconazole	Survived
5 [18]	14	Male	Iraq 1983	Nil	Unknown	Saksenaea sp.	Phenotypic	Cutaneous, Pulmonary	Nil	Died
6 [19]	69	Male	Singapore 2020	Hypertension, Ischaemic heart disease	Unknown	Saksenaea vasiformis complex	Genotypic (ITS sequencing)	Pulmonary, cutaneous, retroperitoneal lesion	IV Amphotericin B, Posaconazole	Survived

ISSN: 1471-2334